Tuesday, March 13, 2012

Japan Gives $340 Million to the Global Fund

One Year After Earthquake and Tsunami,
Japan Makes its Largest-Ever Contribution
to Fight AIDS, Tuberculosis and Malaria

Japan will contribute $340 million this year to the Global Fund to Fight AIDS, Tuberculosis and Malaria. The contribution, part of an $800 million pledge by Japan that it announced in 2010, is the most that Japan has ever given in a decade of support for the international financing institution.

Japan has given more than $1.6 billion to the Global Fund since its creation in 2002.

Japan's contribution in 2010 was $246 million. In 2011, Japan cut its contribution to $114 million following the earthquake and tsunami that devastated the country's northeastern areas.

Japan has always been a leader in the fight against disease, but this is a great vote of confidence in our commitment to saving lives,” said Gabriel Jaramillo, General Manager of the Global Fund. “We recognize Japan’s determination to see real advances in global health, and we are equally determined to deliver.”

Japan's Leadership Began at G8 Summit

Japan’s leadership in the Global Fund began when a summit of G8 nations called for the creation of such a global financing organization in 2000 in Okinawa, Japan.

The Global Fund is a unique, public-private partnership and international financing institution dedicated to attracting and disbursing additional resources to prevent and treat HIV and AIDS, TB and malaria. The organization's model is based on the concepts of country ownership and performance-based funding, which means that people in countries implement their own programs based on their priorities and the Global Fund provides financing on the condition that verifiable results are achieved.

Since its creation, the Global Fund has become the main financier of programs to fight AIDS, TB and malaria, with approved funding of US$ 22.6 billion for more than 1,000 programs in 150 countries. To date, programs supported by the Global Fund are providing AIDS treatment for 3.3 million people, anti-tuberculosis treatment for 8.6 million people and 230 million insecticide-treated nets for the prevention of malaria.